1.Date of institutional investor conference:2022/08/10
2.Time of institutional investor conference:14:30 (Taiwan Time)
3.Location of institutional investor conference:On-line Conference
4.Outline of institutional investor conference:The Company will report its
1H 2022 financial and operating results.
5.Any other matters that need to be specified:Please refer to MOPS or the
Company's website for the presentation materials.
Attachments
Original Link
Original Document
Permalink
Disclaimer
ScinoPharm Taiwan Ltd. published this content on 05 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 August 2022 09:10:02 UTC.
ScinoPharm Taiwan Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of active pharmaceutical ingredients. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The Company is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The Company operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.
SCINOPHARM TAIWAN, LTD. 
